Moreover, it has been reported that the TRPA1 agonist cannabinoid reduces INF-γ in macrophages by inhibiting nitric oxide (NO) production to ameliorate colitis in mice (Romano et al., 2013). This evidence concerns the gene TRPA1 and colitis.